Annual Total Long Term Liabilities
$0.00
-$105.90 K-100.00%
December 31, 2023
Summary
- As of February 7, 2025, ZIVO annual total long term liabilities is $0.00, with the most recent change of -$105.90 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, ZIVO annual total long term liabilities has fallen by -$136.90 thousand (-100.00%).
- ZIVO annual total long term liabilities is now -100.00% below its all-time high of $12.08 million, reached on December 31, 2017.
Performance
ZIVO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, ZIVO quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, ZIVO quarterly long term liabilities has stayed the same.
- ZIVO quarterly long term liabilities is now -100.00% below its all-time high of $16.50 million, reached on March 31, 2018.
Performance
ZIVO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ZIVO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | 0.0% | -100.0% |
ZIVO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
ZIVO Bioscience Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $22.00 K(-56.8%) |
| Jun 2023 | - | $50.90 K(-35.6%) |
| Mar 2023 | - | $79.00 K(-25.4%) |
| Dec 2022 | $105.90 K(>+9900.0%) | $105.90 K(-19.7%) |
| Sep 2022 | - | $131.90 K(-16.0%) |
| Jun 2022 | - | $157.00 K(+9.0%) |
| Mar 2022 | - | $144.10 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2021 | - | $3400.00(-97.4%) |
| Jun 2021 | - | $128.40 K(-2.4%) |
| Mar 2021 | - | $131.60 K(-3.9%) |
| Dec 2020 | $136.90 K(>+9900.0%) | $136.90 K(+12.5%) |
| Sep 2020 | - | $121.70 K(0.0%) |
| Jun 2020 | - | $121.70 K(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $16.50 M(+36.7%) |
| Dec 2017 | $12.08 M(+280.2%) | $12.08 M(+1757.8%) |
| Sep 2017 | - | $650.00 K(-95.4%) |
| Jun 2017 | - | $14.16 M(+0.8%) |
| Mar 2017 | - | $14.05 M(+342.5%) |
| Dec 2016 | $3.18 M(-30.9%) | $3.18 M(-53.4%) |
| Sep 2016 | - | $6.82 M(+40.0%) |
| Jun 2016 | - | $4.87 M(-0.4%) |
| Mar 2016 | - | $4.89 M(+6.3%) |
| Dec 2015 | $4.60 M(+1840.4%) | $4.60 M(+940.7%) |
| Sep 2015 | - | $441.90 K(-49.8%) |
| Jun 2015 | - | $881.00 K(+36.4%) |
| Mar 2015 | - | $645.80 K(+172.5%) |
| Dec 2014 | $237.00 K | $237.00 K(-50.8%) |
| Sep 2014 | - | $481.40 K(-24.3%) |
| Jun 2014 | - | $636.10 K(-37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.01 M(+13.4%) |
| Dec 2013 | $890.80 K(+7.5%) | $890.80 K(+64.1%) |
| Sep 2013 | - | $542.70 K(+35.9%) |
| Jun 2013 | - | $399.40 K(-16.5%) |
| Mar 2013 | - | $478.10 K(-42.3%) |
| Dec 2012 | $828.90 K(+17.3%) | $828.90 K(-26.0%) |
| Sep 2012 | - | $1.12 M(+16.0%) |
| Jun 2012 | - | $966.20 K(+18.1%) |
| Mar 2012 | - | $818.10 K(+15.8%) |
| Dec 2011 | $706.70 K(+38.3%) | $706.70 K(+8.1%) |
| Sep 2011 | - | $653.80 K(+2.8%) |
| Jun 2011 | - | $636.10 K(+34.0%) |
| Mar 2011 | - | $474.80 K(-7.1%) |
| Dec 2010 | $511.10 K(+23.9%) | $511.10 K(+24.9%) |
| Sep 2010 | - | $409.10 K(+58.8%) |
| Jun 2010 | - | $257.70 K(-3.0%) |
| Mar 2010 | - | $265.70 K(-35.6%) |
| Dec 2009 | $412.50 K(+53.0%) | $412.50 K(+6.0%) |
| Sep 2009 | - | $389.00 K(-8.7%) |
| Jun 2009 | - | $425.90 K(+16.8%) |
| Mar 2009 | - | $364.60 K(+35.2%) |
| Dec 2008 | $269.60 K(-23.3%) | $269.60 K(+15.3%) |
| Sep 2008 | - | $233.80 K(+17.2%) |
| Jun 2008 | - | $199.50 K(+5.1%) |
| Mar 2008 | - | $189.80 K(-46.0%) |
| Dec 2007 | $351.40 K(+460.4%) | $351.40 K(-38.7%) |
| Sep 2007 | - | $573.40 K(+682.3%) |
| Jun 2007 | - | $73.30 K(+14.4%) |
| Mar 2007 | - | $64.10 K(+2.2%) |
| Dec 2006 | $62.70 K(>+9900.0%) | $62.70 K(+27.7%) |
| Sep 2006 | - | $49.10 K(+15.3%) |
| Jun 2006 | - | $42.60 K(>+9900.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | - | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00 | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) |
| Jun 2000 | - | $0.00 |
FAQ
- What is ZIVO Bioscience annual total long term liabilities?
- What is the all time high annual total long term liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience annual total long term liabilities year-on-year change?
- What is ZIVO Bioscience quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly long term liabilities year-on-year change?
What is ZIVO Bioscience annual total long term liabilities?
The current annual total long term liabilities of ZIVO is $0.00
What is the all time high annual total long term liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high annual total long term liabilities is $12.08 M
What is ZIVO Bioscience annual total long term liabilities year-on-year change?
Over the past year, ZIVO annual total long term liabilities has changed by -$105.90 K (-100.00%)
What is ZIVO Bioscience quarterly total long term liabilities?
The current quarterly long term liabilities of ZIVO is $0.00
What is the all time high quarterly long term liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly total long term liabilities is $16.50 M
What is ZIVO Bioscience quarterly long term liabilities year-on-year change?
Over the past year, ZIVO quarterly total long term liabilities has changed by $0.00 (0.00%)